Therefore, this review specifically focuses on the direct and indirect regulation of NAFLD/MASLD in aging by CRP and provides a potential target for therapeutic intervention in NAFLD. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.